SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-097396
Filing Date
2011-11-10
Accepted
2011-11-10 12:41:25
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q b87833e10vq.htm 10-Q 242329
2 EX-31.1 b87833exv31w1.htm EX-31.1 8264
3 EX-31.2 b87833exv31w2.htm EX-31.2 8342
4 EX-32.1 b87833exv32w1.htm EX-32.1 2919
5 EX-32.2 b87833exv32w2.htm EX-32.2 2734
  Complete submission text file 0000950123-11-097396.txt   1574692

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT alse-20110930.xml EX-101.INS 161752
7 EX-101 SCHEMA DOCUMENT alse-20110930.xsd EX-101.SCH 13981
8 EX-101 CALCULATION LINKBASE DOCUMENT alse-20110930_cal.xml EX-101.CAL 38082
9 EX-101 LABELS LINKBASE DOCUMENT alse-20110930_lab.xml EX-101.LAB 141394
10 EX-101 PRESENTATION LINKBASE DOCUMENT alse-20110930_pre.xml EX-101.PRE 86985
11 EX-101 DEFINITION LINKBASE DOCUMENT alse-20110930_def.xml EX-101.DEF 17996
Mailing Address 239 SOUTH STREET HOPKINTON MA 01748
Business Address 239 SOUTH STREET HOPKINTON MA 01748 508-497-2360
ALSERES PHARMACEUTICALS INC /DE (Filer) CIK: 0000094784 (see all company filings)

IRS No.: 870277826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-06533 | Film No.: 111194158
SIC: 2834 Pharmaceutical Preparations